Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Other Accumulated Expenses (2016 - 2024)

Innoviva filings provide 15 years of Other Accumulated Expenses readings, the most recent being $17.1 million for Q2 2024.

  • On a quarterly basis, Other Accumulated Expenses fell 23.86% to $17.1 million in Q2 2024 year-over-year; TTM through Jun 2024 was $17.1 million, a 23.86% decrease, with the full-year FY2023 number at $19.7 million, down 7.12% from a year prior.
  • Other Accumulated Expenses hit $17.1 million in Q2 2024 for Innoviva, down from $23.7 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $24.9 million in Q1 2023 to a low of $734000.0 in Q1 2020.
  • Median Other Accumulated Expenses over the past 5 years was $11.6 million (2022), compared with a mean of $11.3 million.
  • Biggest five-year swings in Other Accumulated Expenses: tumbled 44.01% in 2020 and later soared 2043.0% in 2022.
  • Innoviva's Other Accumulated Expenses stood at $1.4 million in 2020, then fell by 28.03% to $1.0 million in 2021, then soared by 2001.78% to $21.2 million in 2022, then decreased by 7.12% to $19.7 million in 2023, then decreased by 13.02% to $17.1 million in 2024.
  • The last three reported values for Other Accumulated Expenses were $17.1 million (Q2 2024), $23.7 million (Q1 2024), and $19.7 million (Q4 2023) per Business Quant data.